Status:
COMPLETED
Refractory Status Epilepticus Treatment: Quality and Efficacy of Coma Induction
Lead Sponsor:
University Hospital, Basel, Switzerland
Conditions:
Status Epilepticus
Refractory Status Epilepticus
Eligibility:
All Genders
18+ years
Brief Summary
This study is to investigate the effects of different treatment characteristics regarding the use of intravenous anesthetic drugs (IVADs) as a rescue treatment for refractory Status epilepticus (RSE) ...
Eligibility Criteria
Inclusion
- diagnosed SE between 2005 and 2019 who have been treated at intensive care units (ICUs) of the University Hospital of Basel
Exclusion
- Patients with repetitive epileptic seizures not qualifying for SE or RSE
- Patients with documented refusal of the general in-house consent
Key Trial Info
Start Date :
April 22 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 3 2022
Estimated Enrollment :
147 Patients enrolled
Trial Details
Trial ID
NCT04333082
Start Date
April 22 2020
End Date
August 3 2022
Last Update
February 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinic for Intensive Care Medicine, University Hospital Basel
Basel, Switzerland, 4031